Home
Epaper
Opinion
India
Video
My Kolkata

News Places People Lifestyle Happenings Food Puja Try This
Edugraph

News Career Campus 18 Under 18 Colleges Workshops
States

West Bengal North East Jharkhand
World
Business
Science & Tech
Health
Sports

Cricket Football Horse Racing
Entertainment
Culture

Bob Dylan@80 Heritage Travel Style People Books Food Arts Music
Gallery

MY KOLKATA EDUGRAPH

Monday, 23 December 2024

Home
Topic
Gilead Sciences

Gilead Sciences

Published 03.10.24, 06:09 AM

Deal on cheaper anti-HIV drug, lenacapavir, for low and lower-middle-income countries

By G.S. Mudur
Published 18.09.24, 05:21 AM

Health activists object to patent filed by US firm Gilead Sciences on anti-HIV drug

By G.S. Mudur
Published 23.07.23, 05:47 AM

Gilead's plan to delay new drug’s release to maximise profits, gaming the US patent system

By Rebecca Robbins, Sheryl Gay Stolberg
Published 12.04.21, 01:27 AM

Ban on export of remdesivir

By G.S. Mudur
Published 01.04.21, 02:25 AM

$8-million connect with city

By Sanjay Mandal